Immunoreactivity for TRK was easily identifiable, as the majority of the positive CRC and NSCLC cases showed diffuse moderate to strong intensity staining except for one case harboring ETV6–NTRK3 fusion. The gene discussed is TPM3; the disease is colorectal carcinoma.